TREASA KURIAN: Open Payments
NPI 1841651619 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 47 payments from 14 companies in 2025. Trend: 2023 $1,230 · 2024 $1,301 · 2025 $1,703
Food & beverage: $1,365Education: $338
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $560 |
| Syndax Pharmaceuticals, Inc. | 6 | $190 |
| SOBI, INC | 7 | $185 |
| Incyte Corporation | 5 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $133 |
| Adaptive Biotechnologies Corporation | 1 | $118 |
| Lilly USA, LLC | 4 | $104 |
| ABBVIE INC. | 2 | $66 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
Products named: Cresemba, Vonjo, CALQUENCE, clonoSEQ, JAKAFI, JAYPIRCA, EPKINLY, Xospata.
Industry payments across TX — which companies pay providers there.
